Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11077108
Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-t
granted patentUS 11072629
Reprogramming of cellular adhesion
granted patentUS 11072600
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treat
granted patentUS 11072594
Trioxolane agents
granted patentUS 11072592
Small molecules that enable cartilage rejuvenation
granted patentUS 11065264
Metal-olsalazine coordination polymers for medical applications
granted patentUS 11065347
Methods for the treatment of Danon disease and other disorders of autophagy
granted patentUS 11066481
Antibodies to coagulation factor XIa and uses thereof
granted patentUS 11066647
Pluripotent human adipose adult stem cells: isolation, characterization and clinical impli
granted patentUS 11065280
Hepatocytes with high regenerative capacity for liver repair
granted patentUS 11061094
Simultaneous pH and oxygen weighted MRI contrast using multi-echo chemical exchange satura
granted patentUS 11058645
Inhibition of respiratory complex III by ligands that interact with a regulatory switch
granted patentUS 11059817
Potent antiviral pyrazolopyridine compounds
granted patentUS 11060087
Synthetic promoters for high throughput screening and gene modulation
granted patentUS 11052044
In situ lipid synthesis for protein reconstitution
granted patentUS 11052089
Methods for inhibiting alpha-v beta-3 expression on cancer stem cells and inhibiting progr
granted patentUS 11053310
Antibodies for the treatment of cancers
granted patentUS 11046941
Methods of generating nucleic acid fragments
granted patentUS 11046730
Antimicrobial compositions
granted patentUS 11045555
Pathogen-specific cargo delivery and diagnostic platform based on mesoporous silica nanopa
granted patentUS 11045493
Synthetic melanin nanoparticles and uses thereof
granted patentUS 11040091
Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods fo
granted patentUS 11041023
Chimeric antigen receptors for phagocytosis
granted patentUS 11033584
Targeted replacement of endogenous T cell receptors
granted